Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis. Academic Article

Overview

authors

Silver, Richard T

Scandura, Joseph M
Abu-Zeinah, Ghaith

publication date

March 3, 2025

published in

Blood neoplasia Journal

Identity

PubMed Central ID

PMC12067890

Digital Object Identifier (DOI)

10.1016/j.bneo.2025.100082

PubMed ID

40453134

Additional Document Info

volume

2

issue

2